Skip to main content
Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
31.82
+0.77 (2.48%)
Dec 20, 2024, 4:00 PM EST - Market closed

Avidity Biosciences Revenue

Avidity Biosciences had revenue of $2.34M in the quarter ending September 30, 2024, a decrease of -17.10%. This brings the company's revenue in the last twelve months to $10.12M, down -0.19% year-over-year. In the year 2023, Avidity Biosciences had annual revenue of $9.56M with 3.64% growth.

Revenue (ttm)
$10.12M
Revenue Growth
-0.19%
P/S Ratio
n/a
Revenue / Employee
$39,988
Employees
253
Market Cap
3.80B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20239.56M336.00K3.64%
Dec 31, 20229.22M-102.00K-1.09%
Dec 31, 20219.33M2.54M37.41%
Dec 31, 20206.79M4.47M192.67%
Dec 31, 20192.32M1.94M511.87%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Organon & Co. 6.41B
Option Care Health 4.78B
DENTSPLY SIRONA 3.90B
ICU Medical 2.34B
Haemonetics 1.36B
Sotera Health Company 1.12B
Prestige Consumer Healthcare 1.11B
PTC Therapeutics 900.66M
Revenue Rankings

RNA News

More News